MUKENI ENGLISH

Drive and implement comprehensive strategies for the launch of Exdensur to enhance market presence in respiratory care, while promoting Nucala for COPD through focused account management.

• 2025 Presidents Club Award Winner, reflecting commitment to excellence in sales and client relations.
• Achieved 106% of sales quota for 2024, contributing to national ranking within the top 30% of sales professionals.
• Evaluated reimbursement and distribution strategies to enhance efficiency in biologic pull-through models.
• Cultivated strong client relationships by managing accounts, ensuring satisfaction and retention through efficient communication and targeted problem resolution.
• Formulated tailored strategies to address client needs, fostering stronger relationships and improved service outcomes.

Promoted and developed expertise in dermatological treatments, such as Humira for rare conditions such as hidradenitis suppurativa (HS).

• Exceeded transaction volume objectives, delivering results of 114.34% for Q3 2022 and 118.53% for Q4 2022.
• Achieved significant transaction growth, outperforming national rates with 80 mg conversions at 23.4%, exceeding the national average of 18.1%.
• Received multiple accolades for exceeding sales targets and demonstrating exceptional product knowledge and execution skills. Supported team efforts in achieving outstanding participation in performance initiatives.
• Engaged with cross-functional teams to ensure alignment of product strategies with customer expectations. - Contract terminated abruptly on a national level, per client

Successfully launched and promoted Jornay PM for ADHD, targeting psychiatrists, pediatrics, and neurologists. Effectively leveraged strategic marketing initiatives to increase patient identification and drive market share. Executed managed care pull-through opportunities with total office calls, triaging coverage issues, and partnering with specialty pharmacies to ensure patient access.

• Ranked #9 among 96 representatives in May 2022, placing in the top 10% nationally.
• 2022 Field Sales Trainer: Coached and developed new and existing team members
• 2021 Presented best practice at the Virtual National Sales Meeting (1 of 2 reps nationally)
• 2021 Ranked top 13% Nationally - 85 representatives
• 2020 Hallo-Winners Contest Winner
• 2019 – Cornerstone Award (President’s Circle Runner-up) - Ranked top 11% Nationally – 376 representatives

Promoted Entresto to Primary Care Physicians in East Texas territory. Effectively impact sales by using consultative selling skills to uncover customer needs. Closed to meet the customer needs based on two-way dialogue discussions.

• Ranked in the top 20% of the Nation for Goal Attainment
• Selected to serve on Sales Leadership Performance Input Council

Caregiver during family member's illness

Successfully launched and promoted Invokana (first-in-class diabetic product) and marketed cardiovascular product – Xarelto to Endocrinologists, Cardiologists and PCPs in the North DFW Area.

• 2-Time President’s Club Award Winner 2015 & 2017
• Ranked in the top 25% Nationally in 2016 (58/232)
• Ranked in the top 14% Nationally in 2014 (23/160)
• Ranked in the top 11% Nationally in 2013 (16/144)

Promote the growth of Orthopedics, Oncology, Neurosurgery, Gastroenterology, Cardiology, General Surgery, Vascular Surgery, Women's Services, and multiple service lines within the hospital by developing new referral sources.

• Collaborated with C-suite to expand Texas Health Resources and integrate newly acquired medical practices.
• 2012 - Increased service line volume by 19%, 2011 - Increased service line volume by 17%, 2010 - Increased service line volume by 13%

Promotion, growth, and marketing of various products, including metabolic, cardiovascular, psychotropic, respiratory and urology medications. Successfully launched Avodart Spring of 2004, ranked #2 in Region and top 10% in Nation. Drove Coreg growth in 2004, 2005, 2006, and 2007, exceeding 100% goal every quarter.

• President’s Club Award Winner 2004
• Rookie of the Year Award Winner 2004
• Business Unit of the Year Award 2007 & 2004
• Successfully launched Lovaza, ranked #3 in Region and top 10% in Nation and Coreg CR, ranked #1 in Region and top 5% in Nation
• Ranked top 12% Nationally (#70/#576) 2006; Ranked top 14% Nationally (#91/#620) 2005; Ranked in the top 5% Nationally (#29/#572) Coreg, Paxil CR, and Avandia in 2004